3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Pain
1
Constipation
1
Interventions
naloxegol
5
Metformin
4
alvimopan
3
Radiotherapy
3
tegaserod
2
Testosterone Propionate
2
Surveys and Questionnaires
2
Standard of Care
2
Liraglutide
2
Glutamine
2
Fibroblast Growth Factor 7
2
Exenatide
2
Early Intervention, Educational
2
semaglutide
1
prucalopride
1
oxycodone-acetaminophen
1
oxycodone naloxone combination
1
lime
1
dapagliflozin
1
cyclohexaneacetic acid
1
bicalutamide
1
acetaminophen, hydrocodone drug combination
1
Testosterone
1
Taxes
1
Tamoxifen
1
Tadalafil
1
Sugars
1
Sugammadex
1
Sucralfate
1
Sodium-Glucose Transporter 2 Inhibitors
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
oxycodone naloxone combination
×
Other
×
Clear all
NCT01014559
2015-09-28
OXN3505
Mundipharma SAS
Phase 3
Terminated
225 enrolled